Skip to main content

FDA Regulatory Due Diligence

Joanne Hawana explains how FDA regulatory due diligence fits into the broader diligence that is done when a transaction involves an FDA-regulated entity as well as what the team is looking for when conducting an FDA regulatory diligence project.

Subscribe To Viewpoints

Author

Joanne S. Hawana is a Member at Mintz who counsels global clients on the regulatory and distribution-related implications when bringing a new FDA-regulated product to market and how to ensure continued compliance after a product is commercialized.